These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29425901)

  • 21. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agreement and Reproducibility of Proton Density Fat Fraction Measurements Using Commercial MR Sequences Across Different Platforms: A Multivendor, Multi-Institutional Phantom Experiment.
    Jang JK; Lee SS; Kim B; Cho ES; Kim YJ; Byun JH; Park BJ; Kim SY; Kim JH
    Invest Radiol; 2019 Aug; 54(8):517-523. PubMed ID: 30913055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
    Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
    Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
    Yokoo T; Serai SD; Pirasteh A; Bashir MR; Hamilton G; Hernando D; Hu HH; Hetterich H; Kühn JP; Kukuk GM; Loomba R; Middleton MS; Obuchowski NA; Song JS; Tang A; Wu X; Reeder SB; Sirlin CB;
    Radiology; 2018 Feb; 286(2):486-498. PubMed ID: 28892458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging.
    Motosugi U; Hernando D; Wiens C; Bannas P; Reeder SB
    Magn Reson Med Sci; 2017 Oct; 16(4):332-339. PubMed ID: 28190853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-care magnetic resonance technology to measure liver fat: Phantom and first-in-human pilot study.
    Barahman M; Grunvald E; Prado PJ; Bussandri A; Henderson WC; Wolfson T; Fowler KJ; Sirlin CB
    Magn Reson Med; 2022 Oct; 88(4):1794-1805. PubMed ID: 35611691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous proton density fat-fraction and
    Thompson RB; Chow K; Mager D; Pagano JJ; Grenier J
    Magn Reson Med; 2021 Jan; 85(1):223-238. PubMed ID: 32754942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hybrid (iron-fat-water) phantom for liver iron overload quantification in the presence of contaminating fat using magnetic resonance imaging.
    Mobini N; Malekzadeh M; Haghighatkhah H; Saligheh Rad H
    MAGMA; 2020 Jun; 33(3):385-392. PubMed ID: 31732894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals.
    Aliyari Ghasabeh M; Shaghaghi M; Khoshpouri P; Pan L; Pandy A; Pandy P; Zhong X; Kannengiesser S; Kamel IR
    Abdom Radiol (NY); 2020 Jan; 45(1):203-210. PubMed ID: 31482380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.
    Kang GH; Cruite I; Shiehmorteza M; Wolfson T; Gamst AC; Hamilton G; Bydder M; Middleton MS; Sirlin CB
    J Magn Reson Imaging; 2011 Oct; 34(4):928-34. PubMed ID: 21769986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.
    Kang BK; Kim M; Song SY; Jun DW; Jang K
    Br J Radiol; 2018 Sep; 91(1089):20170378. PubMed ID: 29022777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
    Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of an Optimized Weighting Factor of Liver Parenchyma for Six-point Interference Dixon Fat Percentage Imaging Accuracy in Nonalcoholic Fatty Liver Disease Rat Model.
    Lee O; Lee SJ; Yu SM
    Acad Radiol; 2018 Dec; 25(12):1595-1602. PubMed ID: 29803754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of Dual-Energy Computed Tomography Techniques for Fat Quantification in Comparison With Magnetic Resonance Proton Density Fat Fraction and Single-Energy Computed Tomography in an Anthropomorphic Phantom Environment.
    Wu ZJ; Hippe DS; Zamora DA; Briller N; Amin KA; Kolokythas O; Mileto A
    J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):877-887. PubMed ID: 34469903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temperature-corrected proton density fat fraction estimation using chemical shift-encoded MRI in phantoms.
    Navaratna R; Zhao R; Colgan TJ; Hu HH; Bydder M; Yokoo T; Bashir MR; Middleton MS; Serai SD; Malyarenko D; Chenevert T; Smith M; Henderson W; Hamilton G; Shu Y; Sirlin CB; Tkach JA; Trout AT; Brittain JH; Hernando D; Reeder SB;
    Magn Reson Med; 2021 Jul; 86(1):69-81. PubMed ID: 33565112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level fat fraction quantification at 3 T: comparative study of different tools for water-fat reconstruction and MR spectroscopy.
    Kořínek R; Gajdošík M; Trattnig S; Starčuk Z; Krššák M
    MAGMA; 2020 Aug; 33(4):455-468. PubMed ID: 31980962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.